Similar Search Results

The Welfare Impact of Parallel Imports: A Structural Approach Applied to the German Market for Oral Anti-diabetics

Duso, T.; Herr, A.; Suppliet, M - Department of Economics and Related Studies, University … - 2014

We investigate the welfare impact of parallel imports using a large panel data set containing monthly information on sales, ex-factory prices, and further product characteristics for all 700 anti-diabetic drugs sold in Germany between 2004 and 2010. We estimate a two-stage nested logit model of...

Persistent link: https://www.econbiz.de/10011133579

Reference pricing with endogenous generic entry.

Brekke, Kurt R.; Canta, Chiara; Straume, Odd Rune - Institutt for samfunnsøkonomi, Norges Handelshøyskole … - 2015

In this paper we study the e¤ect of reference pricing on pharmaceutical prices and expenditures when generic entry is endogenously determined. We develop a Salop-type model where a brand-name producer competes with generic producers in terms of prices. In the market there are two types of...

Persistent link: https://www.econbiz.de/10011261212

The Welfare Impact of Parallel Imports: A Structural Approach Applied to the German Market for Oral Anti-Diabetics

Duso, Tomaso; Herr, Annika; Suppliet, Moritz - DIW Berlin (Deutsches Institut für Wirtschaftsforschung) - 2014

Persistent link: https://www.econbiz.de/10011266596

Reference pricing with endogenous generic entry

Brekke, Kurt R.; Canta, Chiara; Straume, Odd Rune - Núcleo de Investigação em Políticas Económicas … - 2015

In this paper we study the effect of reference pricing on pharmaceutical prices and expenditures when generic entry is endogenously determined. We develop a Salop-type model where a brand-name producer competes with generic producers in terms of prices. In the market there are two types of...

Persistent link: https://www.econbiz.de/10011203036

Margins and market shares: Pharmacy incentives for generic substitution

Brekke, Kurt Richard; Holmås, Tor Helge; Straume, Odd Rune - In: European Economic Review 61 (2013) C, pp. 116-131

generics and their market shares. This relationship is stronger for pharmaceuticals under reference pricing rather than …

Persistent link: https://www.econbiz.de/10011048555

Pharmaceutical followers

Arcidiacono, Peter; Ellickson, Paul B.; Landry, Peter; … - In: International Journal of Industrial Organization 31 (2013) 5, pp. 538-553

We estimate a model of drug demand and supply that incorporates insurance, advertising, and competition between branded …

Persistent link: https://www.econbiz.de/10011051621

The welfare impact of parallel imports: A structural approach applied to the German market for oral anti-diabetics

Duso, Tomaso; Herr, Annika; Suppliet, Moritz - Düsseldorf Institute for Competition Economics (DICE), … - 2014

Persistent link: https://www.econbiz.de/10010956783

Reference pricing, competition, and pharmaceutical expenditures: Theory and evidence from a natural experiment

Brekke, Kurt R.; Holmas, Tor Helge; Straume, Odd Rune - In: Journal of Public Economics 95 (2011) 7, pp. 624-638

We study the impact of regulation on competition between brand-names and generics and pharmaceutical expenditures using …

Persistent link: https://www.econbiz.de/10010574320

“BRANDED GENERICS” AS A STRATEGY TO LIMIT CANNIBALIZATION OF PHARMACEUTICAL MARKETS

Ward, Michael R.; Reiffen, David - Department of Economics, College of Business Administration - 2005

This paper demonstrates how, by introducing a generic version of its previously-patented product, a branded firm can influence the equilibrium in the generic segment of the market for the product. This in turn can increase the firm’s profits from selling the branded version. We then use...

Persistent link: https://www.econbiz.de/10005230146

Price discrimination and investment incentives

Alexandrov, Alexei; Deb, Joyee - In: International Journal of Industrial Organization 30 (2012) 6, pp. 615-623

model to duopoly competition, and find that our results still hold. …

Persistent link: https://www.econbiz.de/10010594868